- Home
- RDZN vs LFCR Comparison
RDZN vs LFCR Comparison
Compare RDZN & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RDZN | LFCR |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | 308 | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.4M | 143.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | RDZN | LFCR |
|---|---|---|
| Price | $1.34 | $5.11 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 795.6K | 230.5K |
| Earning Date | 02-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | $33.77 | N/A |
| Revenue Next Year | $51.46 | $5.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $0.81 | $3.63 |
| 52 Week High | $2.56 | $8.98 |
Technical Indicators
Market Signals| Indicator | RDZN | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 37.52 | 44.68 |
| Support Level | $1.22 | $4.75 |
| Resistance Level | $1.49 | $5.35 |
| Average True Range (ATR) | 0.14 | 0.32 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 5.13 | 25.55 |
Price Performance
Historical ComparisonAbout RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.